Joanne Greena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joanne Greena has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A. Freeman
From the Departments of Neurology (Drs. Green, Vitek, Evatt, Freeman, and DeLong, and S. Triche and B. Sirockman), Psychiatry (Dr. McDonald), and Neurosurgery (Dr. Bakay), Emory University School of Medicine; and Department of Biostatistics (Dr. Haber), Rollins School of Public Health, Emory University, Atlanta, GA
2 shared publicationsB. Sirockman
From the Departments of Neurology (Drs. Green, Vitek, Evatt, Freeman, and DeLong, and S. Triche and B. Sirockman), Psychiatry (Dr. McDonald), and Neurosurgery (Dr. Bakay), Emory University School of Medicine; and Department of Biostatistics (Dr. Haber), Rollins School of Public Health, Emory University, Atlanta, GA
2 shared publicationsM. Evatt
From the Departments of Neurology (Drs. Green, Vitek, Evatt, Freeman, and DeLong, and S. Triche and B. Sirockman), Psychiatry (Dr. McDonald), and Neurosurgery (Dr. Bakay), Emory University School of Medicine; and Department of Biostatistics (Dr. Haber), Rollins School of Public Health, Emory University, Atlanta, GA
2 shared publicationsM. Haber
From the Departments of Neurology (Drs. Green, Vitek, Evatt, Freeman, and DeLong, and S. Triche and B. Sirockman), Psychiatry (Dr. McDonald), and Neurosurgery (Dr. Bakay), Emory University School of Medicine; and Department of Biostatistics (Dr. Haber), Rollins School of Public Health, Emory University, Atlanta, GA
2 shared publicationsS. Triche
From the Departments of Neurology (Drs. Green, Vitek, Evatt, Freeman, and DeLong, and S. Triche and B. Sirockman), Psychiatry (Dr. McDonald), and Neurosurgery (Dr. Bakay), Emory University School of Medicine; and Department of Biostatistics (Dr. Haber), Rollins School of Public Health, Emory University, Atlanta, GA
2 shared publicationsAllan I. Levey
1 shared publication
Latest Publications
- 12 November 2002
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (9) , 1320-1324
Cognitive impairments in advanced PD without dementia
Objective: To determine the nature and frequency of cognitive impairments in nondemented patients with advanced PD and their relationship to other variables potentially predictive of neuropsychological performance. Methods: The neuropsychological performance of nondemented, nondepressed patients with idiopathic PD (n = 61) was quantified with respect to clinically available normative data. The relationship of neuropsychological measures to motor symptoms, age, years of education, disease duration, age at disease onset, disease deterioration rate, and dopaminergic therapy was assessed. Results: Impairment was most frequent on measures sensitive to frontal lobe function (67% on Wisconsin Card Sorting Test number of categories, 30% on letter fluency, 30% on verbal learning). Poorer performance on multiple neuropsychological measures was related to greater overall motor abnormality (total Unified Parkinson’s Disease Rating Scale score), increased bradykinesia on medication, older age, longer disease duration, and reduced education. Conclusions: Even in the absence of dementia or depression, patients with advanced PD are likely to show clinically significant impairments on neuropsychological measures sensitive to changes in dorsolateral prefrontal regions participating in cognitive basal ganglia-thalamocortical circuits.
- 12 November 2002
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (9) , 1320-1324
Cognitive impairments in advanced PD without dementia
Objective: To determine the nature and frequency of cognitive impairments in nondemented patients with advanced PD and their relationship to other variables potentially predictive of neuropsychological performance. Methods: The neuropsychological performance of nondemented, nondepressed patients with idiopathic PD (n = 61) was quantified with respect to clinically available normative data. The relationship of neuropsychological measures to motor symptoms, age, years of education, disease duration, age at disease onset, disease deterioration rate, and dopaminergic therapy was assessed. Results: Impairment was most frequent on measures sensitive to frontal lobe function (67% on Wisconsin Card Sorting Test number of categories, 30% on letter fluency, 30% on verbal learning). Poorer performance on multiple neuropsychological measures was related to greater overall motor abnormality (total Unified Parkinson’s Disease Rating Scale score), increased bradykinesia on medication, older age, longer disease duration, and reduced education. Conclusions: Even in the absence of dementia or depression, patients with advanced PD are likely to show clinically significant impairments on neuropsychological measures sensitive to changes in dorsolateral prefrontal regions participating in cognitive basal ganglia-thalamocortical circuits.
- 26 March 2002
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (6) , 858-865
Neuropsychological and psychiatric sequelae of pallidotomy for PD
Objective: To evaluate the neuropsychological and psychiatric sequelae of unilateral posterior pallidotomy for treatment of PD. Methods: Patients with idiopathic PD completed baseline and 3- and 6-month assessments after random assignment to an immediate surgery (n = 17) or medical management (n = 16) group. Results: Compared with the medical management group, the immediate surgery group with single lesions centered on the posterior internal pallidum showed superior naming and response inhibition, better verbal recall at 6 months, but greater distractibility, a tendency toward lower phonemic fluency, and a transient (3 months’ only) semantic fluency deficit. The group with left lesions had more neuropsychological deficits than the group with right lesions or the medical management group, although these occurred mainly at 3 (but not 6) months. At 6 months, the patients with left lesions showed better verbal memory retention than the patients with right lesions. On most measures, the pattern of individual clinical change did not differ as a function of surgery or lesion laterality, with the exception of a higher frequency of decline in phonemic fluency in the patients with left lesions at 6 months. Although psychiatric status did not change overall, a history of depression tended to increase the risk of a depressive episode following surgery. Conclusions: Well-targeted, uncomplicated, unilateral pallidotomy does not produce overall neuropsychological or psychiatric change, although there are subtle changes on specific measures sensitive to frontal lobe function.
- 26 March 2002
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (6) , 858-865
Neuropsychological and psychiatric sequelae of pallidotomy for PD
Objective: To evaluate the neuropsychological and psychiatric sequelae of unilateral posterior pallidotomy for treatment of PD. Methods: Patients with idiopathic PD completed baseline and 3- and 6-month assessments after random assignment to an immediate surgery (n = 17) or medical management (n = 16) group. Results: Compared with the medical management group, the immediate surgery group with single lesions centered on the posterior internal pallidum showed superior naming and response inhibition, better verbal recall at 6 months, but greater distractibility, a tendency toward lower phonemic fluency, and a transient (3 months’ only) semantic fluency deficit. The group with left lesions had more neuropsychological deficits than the group with right lesions or the medical management group, although these occurred mainly at 3 (but not 6) months. At 6 months, the patients with left lesions showed better verbal memory retention than the patients with right lesions. On most measures, the pattern of individual clinical change did not differ as a function of surgery or lesion laterality, with the exception of a higher frequency of decline in phonemic fluency in the patients with left lesions at 6 months. Although psychiatric status did not change overall, a history of depression tended to increase the risk of a depressive episode following surgery. Conclusions: Well-targeted, uncomplicated, unilateral pallidotomy does not produce overall neuropsychological or psychiatric change, although there are subtle changes on specific measures sensitive to frontal lobe function.
- 1 April 2000
- Published by Elsevier in Brain and Cognition
- Vol. 42 (3) , 379-398
The Impact of Lesion Laterality on Neuropsychological Change Following Posterior Pallidotomy: A Review of Current Findings
- 1 April 2000
- Published by Elsevier in Brain and Cognition
- Vol. 42 (3) , 379-398
The Impact of Lesion Laterality on Neuropsychological Change Following Posterior Pallidotomy: A Review of Current Findings
- Open Access
- 1 November 1999
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 56 (11) , 1398-1403
Event-Related Potential Changes in Groups at Increased Risk for Alzheimer Disease
INDIVIDUALS WHO have a family history (FH) of Alzheimer disease (AD) or who carry the apolipoprotein E (APOE) ϵ4 allele (E4+) are at increased risk for AD.1-7 For blood relatives of patients with AD, the risk of developing the disease approaches 50% after the age of 85 years.1,2 The APOE ϵ4 allele is a major risk factor for both late-onset familial and sporadic AD.4-7 Greater APOE ϵ4 allele dose (carrying 2 ϵ4 alleles rather than 1) is associated with both increased risk and earlier disease onset.4,7
- 1 November 1999
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 56 (11) , 1398-1403
Open AccessEvent-Related Potential Changes in Groups at Increased Risk for Alzheimer Disease
INDIVIDUALS WHO have a family history (FH) of Alzheimer disease (AD) or who carry the apolipoprotein E (APOE) ϵ4 allele (E4+) are at increased risk for AD.1-7 For blood relatives of patients with AD, the risk of developing the disease approaches 50% after the age of 85 years.1,2 The APOE ϵ4 allele is a major risk factor for both late-onset familial and sporadic AD.4-7 Greater APOE ϵ4 allele dose (carrying 2 ϵ4 alleles rather than 1) is associated with both increased risk and earlier disease onset.4,7